43. Recombinant AAV-Mediated Correction of Skeletal Muscle Biochemical and Functional Defects in a Mouse Model of Glycogen Storage Disease Type II, Pompe Disease
2000 ◽
Vol 6
(6)
◽
pp. 245-251
◽
Glycogen storage disease type II (Pompe disease) - influence of enzyme replacement therapy in adults
2009 ◽
Vol 16
(2)
◽
pp. 274-277
◽
1999 ◽
Vol 189
(3)
◽
pp. 416-424
◽